COVID-19_YHLO

YHLO

YHLO

Language

Reproductive Health

Home page

2024/06/05

medRxiv-The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19

2024/06/05

BMJ-Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China cross sectional study

2024/06/05

CMI-Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients

2024/06/05

JITC-SARS-CoV-2 infection in immunocompromised patients humoral versus cell-mediated immunity

2024/06/05

Cell-Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

2024/06/05

Research square-Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low

2024/06/05

Cell Discovery-Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine

2024/06/05

Lancet Infectious Diseases-Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNA

2024/06/05

Levels of Complement Components in Children With Acute COVID-19 or Multisystem Inflammatory Syndrome

2024/06/05

Longitudinal changes of SARS-CoV-2 immunoglobulin G and immunoglobulin M in psychiatric disorders with coronavirus infection

< 1 2 3 4 >

YHLO

Home
Products
- CLIA
  - Analyzers
  - Reagents
- Chemistry
- TLA
- LIA
- ESR
Pubilcations
- Autoimmunity
- Reproductive Health
- Diabetes
- Liver Disease
- Infection
- COVID-19
- ESR
- Others
News
- YHLO News
- Marketing Activities
About YHLO
Contact us
- Career
- Service

Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Tel: +86 755 26601910

Email: marketing@szyhlo.com

youtube

instagram

wechat

wechat

Copyright© 2024 Shenzhen YHLO Biotech Co., Ltd.

Powered by 300.cn | SEO | Business License

8

Email

marketing@szyhlo.com

9

Tel

+86 755 26601910